Keywords: chiron, second-quarter, profits, soar, corp, posted, net
Chiron second-quarter profits soar 70%
Article | 07 August 2000
Chiron Corp has posted second-quarter 2000 net income (from continuingoperations) of $57.4 million, or $0.30 per share, a rise of 70.2%, while revenues increased 27% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
